Joseph Negri

Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity

Douglas W. McMillin, Jake Delmore, Ellen Weisberg et al. · Nature Medicine · 2010 · 313 citations · Full text

Drug Activity, Tumor Biology, Drug Targeting +9

Antitumor Effects of the Proteasome Inhibitor Bortezomib in Medullary and Anaplastic Thyroid Carcinoma Cells in Vitro

Constantine S. Mitsiades, Douglas W. McMillin, Vassiliki Kotoula et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 127 citations · Full text

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

Douglas W. McMillin, Melissa Ooi, Jake Delmore et al. · Cancer Research · 2009 · 122 citations

Niche-based screening identifies small-molecule inhibitors of leukemia stem cells

Kimberly A. Hartwell, Peter G. Miller, Siddhartha Mukherjee et al. · Nature Chemical Biology · 2013 · 108 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Stem Cell Research +6

Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase

Thibaut Imberdis, Joseph Negri, Nagendran Ramalingam et al. · Proceedings of the National Academy of Sciences · 2019 · 98 citations · Full text

Proteinlipid Interaction, Stearoyl-coa Desaturase, Molecular Biology +18